1. Home
  2. LKQ vs PRAX Comparison

LKQ vs PRAX Comparison

Compare LKQ & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LKQ Corporation

LKQ

LKQ Corporation

HOLD

Current Price

$24.92

Market Cap

7.4B

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$319.63

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LKQ
PRAX
Founded
1998
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Motor Vehicles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4B
7.1B
IPO Year
2003
2020

Fundamental Metrics

Financial Performance
Metric
LKQ
PRAX
Price
$24.92
$319.63
Analyst Decision
Buy
Strong Buy
Analyst Count
6
15
Target Price
$42.33
$572.13
AVG Volume (30 Days)
2.5M
514.9K
Earning Date
04-30-2026
05-08-2026
Dividend Yield
3.91%
N/A
EPS Growth
N/A
N/A
EPS
2.35
N/A
Revenue
$13,651,000,000.00
N/A
Revenue This Year
$2.18
N/A
Revenue Next Year
$1.71
$7,758.26
P/E Ratio
$10.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.98
$37.25
52 Week High
$38.91
$366.52

Technical Indicators

Market Signals
Indicator
LKQ
PRAX
Relative Strength Index (RSI) 43.07 52.37
Support Level $24.52 $307.93
Resistance Level $32.12 $343.96
Average True Range (ATR) 0.85 19.22
MACD -0.03 -1.53
Stochastic Oscillator 22.48 46.73

Price Performance

Historical Comparison
LKQ
PRAX

About LKQ LKQ Corporation

LKQ Corp is a world-wide distributor of vehicle products, including replacement parts, components and systems used in the repair and maintenance of vehicles, and specialty aftermarket products and accessories to improve the performance, functionality and appearance of vehicles. The company is organized into three operating segments: North America; Europe; and Specialty segment. It derives maximum revenue from Europe Segment. Europe segment is a provider of alternative vehicle replacement and maintenance products in Germany, the United Kingdom, the Benelux region (Belgium, Netherlands, and Luxembourg), Italy, Czech Republic, Austria, Slovakia, France and various other European countries.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: